Search

everythinglearnresearchcommunity

for

Search:↓

Syphilis can cause hair loss that looks like other conditions, but it improves with treatment.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

There's no significant link between the D19S884 marker at the insulin receptor gene and polycystic ovary syndrome.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Women with PCOS often have liver disease, so liver health checks are important for them.

A young woman's rare ovarian tumor was successfully removed, improving her hormonal symptoms.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

Hormonal imbalances, not insulin resistance or dyslipidemia, may be more important in causing acne in women over 25.

A 13-year-old with 46 XY DSD had ambiguous genitalia due to incomplete masculinization.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.